GGrantIndex
← Leaderboards

Carrie E Bearden

University Of California Los Angeles

$49,487,063
Attributed
$126,197,620
Total exposure
22
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $26.3M · FY200525
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$126,197,620 · 22

By mechanism

U01$96,693,607 · 3
R01$20,848,965 · 5
T32$3,184,177 · 2
R37$2,163,535 · 1
P50$1,217,152 · 1
K23$807,817 · 1

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Genetic

Research focus

GeneticSchizophreniaSymptomsPhenotypeStructureBrainCognitionPsychotic DisordersBaseVariantSamplingLinkFamilyYouthParticipantHigh RiskSyndromeBehavioralPsychopathologyHeterogeneityAffectGenesNeurobehavioralInsight

Grant awards (88)

ProCAN: Psychosis Risk Outcomes Compound Assessment Network$16,589,886
U01 · FY2025 · MH
Neurodevelopment and Psychosis in the 22q11.2 Copy Number Variants$728,795
R37 · FY2025 · MH · contact PI
Training Grant in Neurobehavioral Genetics$547,090
T32 · FY2025 · NS
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics Initiative$521,182
R01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$194,998
U01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$184,327
U01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$182,188
U01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$182,145
U01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$180,329
U01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$170,625
U01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$148,057
U01 · FY2025 · MH
ProNET: Psychosis-Risk Outcomes Network$136,841
U01 · FY2025 · MH
ProCAN: Psychosis Risk Outcomes Compound Assessment Network$14,993,866
U01 · FY2024 · MH
ProNET: Psychosis-Risk Outcomes Network$9,344,586
U01 · FY2024 · MH
Neurodevelopment and Psychosis in the 22q11.2 Copy Number Variants$717,150
R37 · FY2024 · MH · contact PI
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics Initiative$621,319
R01 · FY2024 · MH
Training Grant in Neurobehavioral Genetics$399,517
T32 · FY2024 · NS
3/9 Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders$260,518
U01 · FY2024 · MH · contact PI
ProNET: Psychosis-Risk Outcomes Network$11,636,305
U01 · FY2023 · MH
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial$922,276
R01 · FY2023 · MH
Neurodevelopment and Psychosis in the 22q11.2 Copy Number Variants$717,590
R37 · FY2023 · MH · contact PI
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics Initiative$629,659
R01 · FY2023 · MH
Training Grant in Neurobehavioral Genetics$524,414
T32 · FY2023 · NS
3/9 Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders$260,518
U01 · FY2023 · MH · contact PI
ProNET: Psychosis-Risk Outcomes Network$15,918,096
U01 · FY2022 · MH
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial$1,338,702
R01 · FY2022 · MH
Training Grant in Neurobehavioral Genetics$458,996
T32 · FY2022 · NS
3/9 Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders$260,518
U01 · FY2022 · MH · contact PI
ProNET: Psychosis-Risk Outcomes Network$12,623,656
U01 · FY2021 · MH
ProNET: Psychosis-Risk Outcomes Network$2,115,894
U01 · FY2021 · MH
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial$1,704,981
R01 · FY2021 · MH
Genetics of Severe Mental Illness$975,676
R01 · FY2021 · MH
Training Grant in Neurobehavioral Genetics$436,344
T32 · FY2021 · NS
ProNET: Psychosis-Risk Outcomes Network$10,861,093
U01 · FY2020 · MH
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial$1,477,527
R01 · FY2020 · MH
Genetics of Severe Mental Illness$1,100,859
R01 · FY2020 · MH
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$672,852
R01 · FY2020 · MH · contact PI
3/9 Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders$188,643
U01 · FY2020 · MH · contact PI
Training Grant in Neurobehavioral Genetics$175,166
T32 · FY2020 · MH · contact PI
3/9 Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders$71,875
U01 · FY2020 · MH · contact PI
Genetics of Severe Mental Illness$1,100,628
R01 · FY2019 · MH
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$861,675
R01 · FY2019 · MH · contact PI
Genetics of Severe Mental Illness$263,983
R01 · FY2019 · MH
Neurobiological basis of dysconnectivity in a genetic risk model of psychosis$194,982
R21 · FY2019 · MH · contact PI
3/9 Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders$188,643
U01 · FY2019 · MH · contact PI
Training Grant in Neurobehavioral Genetics$172,989
T32 · FY2019 · MH · contact PI
Genetics of Severe Mental Illness$1,100,628
R01 · FY2018 · MH
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$858,912
R01 · FY2018 · MH · contact PI
Neurobiological basis of dysconnectivity in a genetic risk model of psychosis$171,422
R21 · FY2018 · MH · contact PI
Training Grant in Neurobehavioral Genetics$147,860
T32 · FY2018 · MH · contact PI
Genetics of Severe Mental Illness$1,235,019
R01 · FY2017 · MH
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$710,809
R01 · FY2017 · MH · contact PI
Genetic Risk for Developmental Expression of Neuropsychiatric Intermediate Traits$510,364
R01 · FY2017 · MH · contact PI
Training Grant in Neurobehavioral Genetics$155,033
T32 · FY2017 · MH · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$149,877
R01 · FY2017 · MH · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$714,789
R01 · FY2016 · MH · contact PI
Genetic Risk for Developmental Expression of Neuropsychiatric Intermediate Traits$510,364
R01 · FY2016 · MH · contact PI
Training Grant in Neurobehavioral Genetics$166,768
T32 · FY2016 · MH · contact PI
Genetic Risk for Developmental Expression of Neuropsychiatric Intermediate Traits$126,560
R01 · FY2016 · MH · contact PI
Integration of Five Large-Scale Neuropsychiatric Genetic Datasets under the RDoC Framework$77,000
R03 · FY2016 · MH
Genetic Risk for Developmental Expression of Neuropsychiatric Intermediate Traits$512,674
R01 · FY2015 · MH · contact PI
Integration of Five Large-Scale Neuropsychiatric Genetic Datasets under the RDoC Framework$77,000
R03 · FY2015 · MH
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$460,109
R01 · FY2014 · MH · contact PI
Core 4- Prodromal Research Program$245,096
P50 · FY2014 · MH · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$105,446
R01 · FY2014 · MH · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$484,850
R01 · FY2013 · MH · contact PI
Core 4- Prodromal Research Program$235,050
P50 · FY2013 · MH · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$394,568
R01 · FY2012 · MH · contact PI
Core 4- Prodromal Research Program$244,844
P50 · FY2012 · MH · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$90,419
R01 · FY2012 · MH · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$353,084
R01 · FY2011 · MH · contact PI
Core 4- Prodromal Research Program$244,844
P50 · FY2011 · MH · contact PI
Neurofibromatosis Type I as a Model for Therapeutic Neuroadaptation$228,690
R34 · FY2011 · MH · contact PI
IDENTIFICATION OF ENDOPHENOTYPES FOR BIPOLAR DISORDER$10,135
P41 · FY2011 · RR · contact PI
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome$339,174
R01 · FY2010 · MH · contact PI
Core 4- Prodromal Research Program$247,318
P50 · FY2010 · MH · contact PI
Neurofibromatosis Type I as a Model for Therapeutic Neuroadaptation$231,000
R34 · FY2010 · MH · contact PI
IDENTIFICATION OF ENDOPHENOTYPES FOR BIPOLAR DISORDER$12,157
P41 · FY2010 · RR · contact PI
Neurofibromatosis Type I as a Model for Therapeutic Neuroadaptation$231,000
R34 · FY2009 · MH · contact PI
Identification of endophenotypes for bipolar disorder$162,013
K23 · FY2009 · MH · contact PI
IDENTIFICATION OF ENDOPHENOTYPES FOR BIPOLAR DISORDER$13,597
P41 · FY2009 · RR · contact PI
Identification of endophenotypes for bipolar disorder$161,207
K23 · FY2008 · MH · contact PI
IDENTIFICATION OF ENDOPHENOTYPES FOR BIPOLAR DISORDER$5,153
P41 · FY2008 · RR · contact PI
Identification of endophenotypes for bipolar disorder$161,488
K23 · FY2007 · MH · contact PI
IDENTIFICATION OF ENDOPHENOTYPES FOR BIPOLAR DISORDER$20,076
P41 · FY2007 · RR · contact PI
Identification of endophenotypes for bipolar disorder$161,751
K23 · FY2006 · MH · contact PI
IDENTIFICATION OF ENDOPHENOTYPES FOR BIPOLAR DISORDER$10,155
P41 · FY2006 · RR · contact PI
Identification of endophenotypes for bipolar disorder$161,358
K23 · FY2005 · MH